phosphoserine has been researched along with Parkinsonian Disorders in 3 studies
Phosphoserine: The phosphoric acid ester of serine.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It is thought that Parkinson's disease involves apoptosis, and NGF prevents apoptosis in an in vivo model system." | 1.31 | Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease. ( Chiba, H; Shimoke, K, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Covy, JP | 1 |
| Yuan, W | 1 |
| Waxman, EA | 1 |
| Hurtig, HI | 1 |
| Van Deerlin, VM | 1 |
| Giasson, BI | 1 |
| Hirai, Y | 1 |
| Fujita, SC | 1 |
| Iwatsubo, T | 1 |
| Hasegawa, M | 1 |
| Shimoke, K | 1 |
| Chiba, H | 1 |
3 other studies available for phosphoserine and Parkinsonian Disorders
| Article | Year |
|---|---|
Clinical and pathological characteristics of patients with leucine-rich repeat kinase-2 mutations.
Topics: Aged; alpha-Synuclein; Amino Acid Sequence; Cohort Studies; DNA Mutational Analysis; Female; Genes, | 2009 |
Phosphorylated alpha-synuclein in normal mouse brain.
Topics: Aging; alpha-Synuclein; Animals; Brain; Cerebral Cortex; Corpus Striatum; Hippocampus; Male; Mice; M | 2004 |
Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acid Chloromethyl Ketones; Amino Acid Substituti | 2001 |